Covalon Technologies announced on March 31, 2020 is working on a technology called CovaGuard, which is formulated to be effective at killing pathogens like the COVID-19 virus on contact with the added benefit of providing protection.

The company filed for a patent on CovaGuard technology. Usually this means there is high hopes that this can actually work and be effective. When new treatments are being made, they have to be tested for effectiveness, and safety.


Businesswire | Covalon




What is COVID-19?

COVID-19 virus or SARS-CoV-2 is a new disease which was first itdentified in Wuhan, China in December 2019. The virus has spread globally, causing the current 2019-2020 coronavirus pandemic.


Symptoms include fever, cough and shortness of breath. Although 560,000 people have currently recovered, it has caused 2,196,109 cases and 149,024 deaths world wide.


There is no vaccine currently available as of April 2020, however many vaccines are currently in trials and hopefully by spring 2021, there will be one for the general public.